Page last updated: 2024-08-23

paroxetine and Menopause

paroxetine has been researched along with Menopause in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (3.57)18.2507
2000's9 (32.14)29.6817
2010's17 (60.71)24.3611
2020's1 (3.57)2.80

Authors

AuthorsStudies
Crandall, CJ; Manson, JE; Mehta, JM1
Dobs, AS1
Bhaskar, S; Kaunitz, AM; Kazempour, K; Lippman, J; Mekonnen, H; Portman, DJ; Simon, JA1
Bhaskar, S; Kaunitz, AM; Kazempour, K; Lippman, J; Mekonnen, H; Portman, DJ1
Chandler, J; Denker, AE; Gottesdiener, K; He, W; Lazarus, N; Rosenberg, E; Simon, JA; Wagner, JA1
Handley, AP; Williams, M1
Pines, A1
Carris, N; Kutner, S; Reilly-Rogers, S1
Bachmann, G1
Champion, MN; Palmore, KB; Slaton, RM1
Jacob, JA1
Pinkerton, JV1
Huang, S; Liu, C; Liu, X; Ye, Y1
Aloisi, A; Angioli, R; Capriglione, S; Lopez, S; Luvero, D; Montera, R; Plotti, F; Scaletta, G; Serra, GB1
Crider, M; Hill, DA; Hill, SR1
Bazanella Sampaio, T; Mozzaquatro Gai, B; Nogueira, CW; Pinton, S; Trevisan da Rocha, J; Zeni, G1
Beebe, KL; Dube, E; Iyengar, M; Stearns, V1
Yonkers, KA1
Baber, R; Hickey, M; Kwik, M1
Albertazzi, P1
Stearns, V1
Alexander, IM; Moore, A1
Ikeda, A; Ueki, M; Ushiroyama, T1
Egawa, T; Ikeda, M; Kataoka, Y; Koga, A; Shuto, H; Sohda, Y; Tominaga, K; Yamauchi, A1
Amsterdam, JD; Garcia-EspaƱa, F; Goodman, D; Hooper, M; Hornig-Rohan, M1
Crawford, J; Ellis, MJ; Hanfelt, JJ; Hayes, DF; Isaacs, C; Kramer, R; Lawrence, W; Rowland, J; Stearns, V1

Reviews

9 review(s) available for paroxetine and Menopause

ArticleYear
Management of Menopausal Symptoms: A Review.
    JAMA, 2023, 02-07, Volume: 329, Issue:5

    Topics: Autonomic Nervous System Diseases; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Female Urogenital Diseases; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Neoplasms; Paroxetine; Sweating; Venlafaxine Hydrochloride; Venous Thromboembolism

2023
The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.
    Journal of the American Association of Nurse Practitioners, 2015, Volume: 27, Issue:1

    Topics: Adult; Aged; Citalopram; Desvenlafaxine Succinate; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Vasomotor System; Venlafaxine Hydrochloride

2015
New pharmacological therapies for vasomotor symptom management: focus on bazedoxifene/conjugated estrogens and paroxetine mesylate.
    The Annals of pharmacotherapy, 2014, Volume: 48, Issue:10

    Topics: Clinical Trials as Topic; Drug Combinations; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Mesylates; Paroxetine; Vasomotor System

2014
A review of paroxetine for the treatment of vasomotor symptoms.
    Journal of pharmacy practice, 2015, Volume: 28, Issue:3

    Topics: Antidepressive Agents, Second-Generation; Female; Hot Flashes; Humans; Menopause; Paroxetine

2015
Hormone Therapy and Other Treatments for Symptoms of Menopause.
    American family physician, 2016, Dec-01, Volume: 94, Issue:11

    Topics: Acupuncture Therapy; Administration, Intravaginal; Amines; Antidepressive Agents; Atrophy; Cyclohexanecarboxylic Acids; Dietary Supplements; Drug Therapy, Combination; Dyspareunia; Estrogen Replacement Therapy; Estrogens; Exercise Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Hypnosis; Indoles; Menopause; Paroxetine; Progestins; Selective Estrogen Receptor Modulators; Tamoxifen; Vagina; Vaginal Diseases; Vasomotor System; Venlafaxine Hydrochloride

2016
Paroxetine treatment of mood disorders in women: premenstrual dysphoric disorder and hot flashes.
    Psychopharmacology bulletin, 2003,Spring, Volume: 37 Suppl 1

    Topics: Antidepressive Agents, Second-Generation; Female; Hot Flashes; Humans; Menopause; Mood Disorders; Paroxetine; Premenstrual Syndrome

2003
Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations.
    Drug safety, 2005, Volume: 28, Issue:12

    Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Clonidine; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Health Behavior; Hot Flashes; Humans; Menopause; Norpregnenes; Paroxetine; Personal Health Services; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Tamoxifen

2005
Noradrenergic and serotonergic modulation to treat vasomotor symptoms.
    The journal of the British Menopause Society, 2006, Volume: 12, Issue:1

    Topics: Citalopram; Cyclohexanols; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Mianserin; Mirtazapine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Trazodone; Venlafaxine Hydrochloride

2006
Treating vasomotor symptoms of menopause: the nurse practitioner's perspective.
    Journal of the American Academy of Nurse Practitioners, 2007, Volume: 19, Issue:3

    Topics: Adrenergic alpha-Agonists; Algorithms; Amines; Citalopram; Clonidine; Complementary Therapies; Cyclohexanecarboxylic Acids; Estrogen Replacement Therapy; Evidence-Based Medicine; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Life Style; Menopause; Middle Aged; Nurse Practitioners; Paroxetine; Patient Education as Topic; Patient Selection; Practice Guidelines as Topic; Primary Health Care; Safety Management; Selective Serotonin Reuptake Inhibitors

2007

Trials

7 trial(s) available for paroxetine and Menopause

ArticleYear
Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials.
    Menopause (New York, N.Y.), 2013, Volume: 20, Issue:10

    Topics: Adult; Double-Blind Method; Female; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Placebos; Postmenopause; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2013
Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause.
    Menopause (New York, N.Y.), 2014, Volume: 21, Issue:10

    Topics: Adult; Aged; Body Mass Index; Body Weight; Female; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Single-Blind Method

2014
Diary of hot flashes reported upon occurrence: results of a randomized double-blind study of raloxifene, placebo, and paroxetine.
    Menopause (New York, N.Y.), 2014, Volume: 21, Issue:9

    Topics: Adult; Double-Blind Method; Female; Hormone Replacement Therapy; Hot Flashes; Humans; Medical Records; Menopause; Middle Aged; Paroxetine; Raloxifene Hydrochloride; Reproducibility of Results; Selective Estrogen Receptor Modulators; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome

2014
Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial.
    Gynecologic oncology, 2016, Volume: 143, Issue:3

    Topics: Adult; Aged; Double-Blind Method; Female; Genital Neoplasms, Female; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Wake Disorders; Survivors; Treatment Outcome

2016
Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.
    JAMA, 2003, Jun-04, Volume: 289, Issue:21

    Topics: Adult; Aged; Delayed-Action Preparations; Double-Blind Method; Female; Health Status Indicators; Hot Flashes; Humans; Logistic Models; Menopause; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2003
Evaluation of double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients in menopause transition.
    Journal of medicine, 2004, Volume: 35, Issue:1-6

    Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans; Menopause; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors

2004
A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:1

    Topics: Adult; Aged; Anxiety; Breast Neoplasms; Confidence Intervals; Depression; Female; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Pilot Projects; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Surveys and Questionnaires; Survivors

2000

Other Studies

12 other study(ies) available for paroxetine and Menopause

ArticleYear
A little better than placebo is still better than nothing.
    Nature medicine, 2013, Volume: 19, Issue:8

    Topics: Dose-Response Relationship, Drug; Female; Humans; Menopause; Paroxetine; Placebos; Randomized Controlled Trials as Topic; Treatment Outcome; United States; United States Food and Drug Administration

2013
Paroxetine (Brisdelle) for hot flashes.
    The Medical letter on drugs and therapeutics, 2013, Oct-28, Volume: 55, Issue:1428

    Topics: Drug Interactions; Female; Hot Flashes; Humans; Menopause; Paroxetine; Selective Serotonin Reuptake Inhibitors

2013
Safety of low-dose paroxetine.
    Climacteric : the journal of the International Menopause Society, 2014, Volume: 17, Issue:3

    Topics: Body Weight; Female; Hot Flashes; Humans; Menopause; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological

2014
Another option for menopausal vasomotor symptoms without negative impact on weight and sexual function.
    Menopause (New York, N.Y.), 2014, Volume: 21, Issue:10

    Topics: Body Weight; Female; Hot Flashes; Humans; Menopause; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological

2014
Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society.
    Menopause (New York, N.Y.), 2015, Volume: 22, Issue:11

    Topics: Behavior Therapy; Cognitive Behavioral Therapy; Exercise; Female; Health Education; Hot Flashes; Humans; Menopause; Paroxetine; Practice Guidelines as Topic; Relaxation; Societies, Medical; United States; Vascular Diseases; Vasomotor System; Women's Health; Yoga

2015
Can Nonhormonal Treatments Dial Down the Heat During Menopause?
    JAMA, 2016, Jan-05, Volume: 315, Issue:1

    Topics: Advisory Committees; Antidepressive Agents; Cognitive Behavioral Therapy; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Hypnosis; Menopause; Paroxetine; Phytotherapy; Selective Serotonin Reuptake Inhibitors; Stellate Ganglion

2016
Dose is important for nonhormonal therapy for hot flashes.
    BJOG : an international journal of obstetrics and gynaecology, 2016, Volume: 123, Issue:11

    Topics: Hot Flashes; Humans; Menopause; Paroxetine; Selective Serotonin Reuptake Inhibitors

2016
Ovariectomy changes the response to antidepressant drugs in tail suspension test in mice.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2016, Volume: 32, Issue:12

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Doxepin; Estrogens; Female; Hindlimb Suspension; Menopause; Mice; Mice, Inbred ICR; Ovariectomy; Paroxetine; Venlafaxine Hydrochloride

2016
Effects of diphenyl diselenide on depressive-like behavior in ovariectomized mice submitted to subchronic stress: involvement of the serotonergic system.
    Psychopharmacology, 2012, Volume: 222, Issue:4

    Topics: Animals; Antidepressive Agents; Benzene Derivatives; Cerebral Cortex; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Female; Hippocampus; Immobility Response, Tonic; Menopause; Mice; Mice, Inbred Strains; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Ondansetron; Organoselenium Compounds; Ovariectomy; Pargyline; Paroxetine; Piperazines; Pyridines; Ritanserin; Serotonergic Neurons; Serotonin Antagonists; Stress, Psychological

2012
Serotonergic agents as an alternative to hormonal therapy for the treatment of menopausal vasomotor symptoms.
    Treatments in endocrinology, 2006, Volume: 5, Issue:2

    Topics: Antineoplastic Agents, Hormonal; Hot Flashes; Humans; Menopause; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors

2006
Selective serotonin reuptake inhibitors fluvoxamine and paroxetine restore forced exercise-induced temperature dysregulation in ovariectomized mice.
    European journal of pharmacology, 2008, Jan-28, Volume: 579, Issue:1-3

    Topics: Animals; Dose-Response Relationship, Drug; Estradiol; Estrogens; Female; Fluvoxamine; Hot Flashes; Humans; Menopause; Mice; Mice, Inbred ICR; Models, Animal; Ovariectomy; Paroxetine; Physical Conditioning, Animal; Selective Serotonin Reuptake Inhibitors; Skin Temperature; Tail

2008
Breast enlargement during chronic antidepressant therapy.
    Journal of affective disorders, 1997, Volume: 46, Issue:2

    Topics: Breast; Breast Diseases; Cyclohexanols; Depressive Disorder; Female; Fluoxetine; Humans; Hyperplasia; Male; Menopause; Paroxetine; Prolactin; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Weight Gain

1997